Daré Bioscience receives $851,796 in additional contraceptive research grant funding
DARE•Daré Bioscience received $851,796 under an existing grant agreement worth up to approximately $10.7 million to support development of a non-hormonal intravaginal contraceptive for women in low- and middle-income countries.
1. Grant funding
The $851,796 payment is the second-to-last anticipated tranche under the grant agreement. Future funding depends on additional milestones.




